HK1025732A1 - Wound healing and treatment of fibrosis - Google Patents

Wound healing and treatment of fibrosis

Info

Publication number
HK1025732A1
HK1025732A1 HK00101571A HK00101571A HK1025732A1 HK 1025732 A1 HK1025732 A1 HK 1025732A1 HK 00101571 A HK00101571 A HK 00101571A HK 00101571 A HK00101571 A HK 00101571A HK 1025732 A1 HK1025732 A1 HK 1025732A1
Authority
HK
Hong Kong
Prior art keywords
fibrosis
treatment
wound healing
compound
gelsolin
Prior art date
Application number
HK00101571A
Other languages
English (en)
Inventor
Mark William James Ferguson
Sharon O'kane
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9625148.3A external-priority patent/GB9625148D0/en
Application filed by Renovo Ltd filed Critical Renovo Ltd
Publication of HK1025732A1 publication Critical patent/HK1025732A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HK00101571A 1996-12-04 2000-03-15 Wound healing and treatment of fibrosis HK1025732A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9625148.3A GB9625148D0 (en) 1996-12-04 1996-12-04 Wound healing
US3211596P 1996-12-05 1996-12-05
PCT/GB1997/003243 WO1998024465A1 (en) 1996-12-04 1997-12-04 Wound healing and treatment of fibrosis

Publications (1)

Publication Number Publication Date
HK1025732A1 true HK1025732A1 (en) 2000-11-24

Family

ID=26310539

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00101571A HK1025732A1 (en) 1996-12-04 2000-03-15 Wound healing and treatment of fibrosis

Country Status (12)

Country Link
US (2) US20020103112A1 (de)
EP (1) EP0941108B1 (de)
JP (1) JP2001505219A (de)
AT (1) ATE226084T1 (de)
AU (1) AU744750B2 (de)
CA (1) CA2274002A1 (de)
DE (1) DE69716460T2 (de)
DK (1) DK0941108T3 (de)
ES (1) ES2183220T3 (de)
HK (1) HK1025732A1 (de)
PT (1) PT941108E (de)
WO (1) WO1998024465A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000009070A2 (en) * 1998-08-13 2000-02-24 Hadasit Medical Research Services And Development Company Ltd. Inhibition of pathogenic processes related to tissue trauma
CA2388761A1 (en) * 2001-06-18 2002-12-18 Pfizer Inc. Wound healing biomarkers
US7301020B2 (en) * 2003-06-19 2007-11-27 Wisconsin Alumni Research Foundation Macrolide analogs and methods for identifying same
US9408891B2 (en) * 2003-11-12 2016-08-09 The Trustees Of The University Of Pennsylvania Methods of using gelsolin to treat or prevent bacterial sepsis
CA2545718C (en) * 2003-11-12 2016-05-10 The Trustees Of The University Of Pennsylvania Methods of using gelsolin to treat or prevent bacterial sepsis
CA2860173C (en) * 2004-05-12 2021-12-14 The Brigham And Women's Hospital, Inc. Determining plasma gelsolin level to predict risk of developing infection
CA2665717C (en) 2005-10-25 2016-01-19 Women's & Children's Health Research Institute Methods and compositions comprising a flightless i antagonist for modulating wound repair
AU2006308431B2 (en) * 2005-10-25 2011-11-10 Adelaide Research & Innovation Pty Ltd Methods and compositions for modulating wound repair
PT2002258T (pt) * 2006-03-15 2017-12-18 The Brigham And Women`S Hospital Inc Utilização de gelsolina para o tratamento da esclerose múltipla e para o diagnóstico de doenças neurológicas
JP5322917B2 (ja) 2006-03-15 2013-10-23 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド 炎症性疾患の診断および処置のためのゲルゾリンの使用
GB0724231D0 (en) * 2007-12-12 2008-01-30 Renono Ltd Methods for inhibiting scarring
ES2531827T3 (es) * 2008-01-25 2015-03-20 The General Hospital Corporation Usos terapéuticos de gelsolina en insuficiencia renal
GB201003652D0 (en) * 2010-03-05 2010-04-21 Univ Cardiff Molecular target for healing or treating wounds
EP3263121B1 (de) * 2010-12-21 2019-02-27 Leidos, Inc. Verfahren und zusammensetzungen zur wundbehandlung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929442A (en) 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
EP0280560B1 (de) 1987-02-27 1994-05-11 EASTMAN KODAK COMPANY (a New Jersey corporation) Mit Nieder-pI-Protein beschichtete Membranstruktur und Verfahren zu ihrer Herstellung und Verwendung
US4950483A (en) * 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5242902A (en) * 1989-09-06 1993-09-07 The Regents Of The University Of California Defensin peptide compositions and methods for their use
DK0526544T3 (da) 1990-04-11 1999-06-21 Brigham & Womens Hospital Terapeutiske anvendelser af actinbindende forbindelser
US5464817A (en) * 1990-04-11 1995-11-07 Brigham And Women's Hospital Method for reducing the viscosity of pathological mucoid airway contents in the respiratory tract comprising administering actin-binding compounds with or without DNASE I
WO1993004164A1 (en) 1991-08-26 1993-03-04 THE STATE OF OREGON acting by and through THE STATE OF BOARD OF HIGHER EDUCATION on behalf of THE OREGON HEALTH SCIENCES UNIVERSITY Keratinocyte-derived conditioned medium as a source of growth factors
GB9206861D0 (en) * 1992-03-28 1992-05-13 Univ Manchester Wound healing and treatment of fibrotic disorders
GB2304047A (en) * 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines

Also Published As

Publication number Publication date
AU5401098A (en) 1998-06-29
PT941108E (pt) 2003-01-31
DK0941108T3 (da) 2002-11-18
DE69716460D1 (de) 2002-11-21
US7566446B2 (en) 2009-07-28
US20070087969A1 (en) 2007-04-19
WO1998024465A1 (en) 1998-06-11
EP0941108A1 (de) 1999-09-15
ATE226084T1 (de) 2002-11-15
ES2183220T3 (es) 2003-03-16
JP2001505219A (ja) 2001-04-17
US20020103112A1 (en) 2002-08-01
AU744750B2 (en) 2002-02-28
EP0941108B1 (de) 2002-10-16
CA2274002A1 (en) 1998-06-11
DE69716460T2 (de) 2003-06-26

Similar Documents

Publication Publication Date Title
HK1025732A1 (en) Wound healing and treatment of fibrosis
IL116479A0 (en) Antifungal compositions and bandage for treatment of nails
AU2595697A (en) Compounds and compositions for delivering active agents
HK1017995A1 (en) Compounds and compositions for delivering active agents.
ZA949418B (en) Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
GR1003011B (el) Νεα συνθεση
AU5296593A (en) Concentrated mouthrinse for efficient delivery of antimicrobials
ZA933023B (en) The use of inhibitors of plasminogen activators for the treatment of inflammations and wounds.
EP0640647A3 (de) Ionisch vernetzte Gele aus Glykosaminoglykan zur Vermehrung von Weichgewebe und Arzneimittelabgabe.
AU697311B2 (en) Combined preparation for the therapy of immunological diseases
CA2186269A1 (en) Wound healing
WO1994008613A3 (en) Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
ZA936692B (en) Physiologically active peptide composition
WO1998053850A3 (en) Compositions and means for the treatment of burns and other cutaneous traumas
SG47158A1 (en) Improving the tolerability of pharmaceutically active b-amino acids
AU3733293A (en) Method and agents for promoting wound healing
AU5531798A (en) Pharmacologically active compounds and use
EP0959887A4 (de) Pharmazeutisch wirksame verbindungen und verfahren zu ihrer verwendung
AU1720097A (en) Biologically active ureido derivatives useful in the treatment of multiple sclerosis
AU8393391A (en) Splint and bandage applicator
GB9205784D0 (en) Biologically and therapeutically active agents against hiv-1
GB9306974D0 (en) Biologically and therapeutically active agents against hiv-1
HUP9901162A3 (en) Compounds and compositions for delivering active agents
ZA929143B (en) Agents for use in the prophylaxis and therapy of fungal infections.
GB9315411D0 (en) Active agent delivery

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20111204